Category Archives: Gadolinium

Featured Stories

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Fracking Should be Kept 600m From Aquifers, Study Says

New research on the safety of hydraulic fracturing (fracking) suggests new wells should not be dug within 600 meters of a water aquifer because underground fractures can extend about that far from a dug well. According to a report from UK’s The Guardian newspaper, researchers and geologists at Durham University have ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Scientist Calls for Federal Regulations for Fracking Pollution

Hydraulic fracturing (fracking) drilling should be governed by federal regulations because its pollution has no awareness of state boundaries.

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Omniscan NSF Lawsuit Settled

What would have been the first < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan lawsuit to go to a jury trial was settled at the last minute. The terms of the settlement are confidential, according to a report on ProPublica. Omniscan is gadolinium contrast dye that … Continue reading

Posted in Gadolinium, Pharmaceuticals |

First Omniscan Jury Trial Starts Today

The first jury trial involving General Electric’s < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye is scheduled to begin today. The plaintiff in the lawsuit, an elderly Minnesota woman, claims she developed nephrogenic systemic fibrosis (NSF) after being injected with Omniscan as part … Continue reading

Posted in Gadolinium, Pharmaceuticals |

Fewer Kidney Patients Received Gadolinium Agents Following 2006 NSF Alert

Fewer kidney patients have received < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dyes during MR studies since the US Food & Drug Administration (FDA) first issued warnings about their association with nephrogenic systemic fibrosis (NSF) in 2006. NSF is a condition involving the formation … Continue reading

Posted in Gadolinium, Pharmaceuticals |

FDA Strengthens Warnings on Gadolinium MRI Dyes

Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA for use with … Continue reading

Posted in Gadolinium, Pharmaceuticals |

Dutch Regulators Fault GE for Failing to Report Omniscan NSF Case

The Danish Medicines Agency has charged that GE Healthcare violated Dutch law when it failed to promptly and completely inform regulators about a patient who died after developing nephrogenic systemic fibrosis (NSF) following exposure to < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan contrast dye. According … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Healthcare Advised to Restrict Omniscan in 2006

GE Healthcare’s own experts recommended in May 2006 that it proactively restrict the use of < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan, a gadolinium contrast dye, after it was linked to nephrogenic systemic fibrosis (NSF). According to a ProPublica investigation, rather than take that advice, … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Drops Omniscan Libel Suit

GE Healthcare has dropped a libel suit it filed in the United Kingdom (UK) against a Danish researcher who had who warned its < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye was associated with nephrogenic systemic fibrosis (NSF) in 2007. When GE Healthcare sued … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Using UK Libel Laws to Shield Omniscan from Criticism, Doctor Claims

General Electric has been accused of trying to stifle criticism of its < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye by a Danish radiologist who warned it was associated with nephrogenic systemic fibrosis (NSF) in 2007. According to an article in The Guardian, … Continue reading

Posted in Gadolinium, Pharmaceuticals |

FDA Should Tighten Restrictions on Omniscan, OptiMark, Panel Says

A panel of medical experts reviewing gadolinium contrast dyes recommended last week that the labeling for General Electric’s Omniscan and Covidien’s OptiMark should have stronger warnings regarding their risk of < "http://www.yourlawyer.com/topics/overview/nsf">nephrogenic systemic fibrosis (NSF). According to an article on … Continue reading

Posted in Gadolinium, Pharmaceuticals |

First NSF Lawsuit to Go to Trial in California

One of the first trials involving a < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye – Magnevist – and nephrogenic systemic fibrosis (NSF) is set to begin in January. According to a report on Law.com, the outcome of the Magnevist trial could be a … Continue reading

Posted in Gadolinium, Pharmaceuticals |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.